The Use of Ranolazine in the Management of Recurrent Atrial Fibrillation After Percutaneous Radiofrequency Ablation

Journal of Atrial Fibrillation
Angelo BivianoJames Reiffel

Abstract

Long-term medical treatment options for atrial fibrillation (AF) include rate-control as well as rhythm-control therapy with various antiarrhythmics. However, because of the limited efficacy and potential side effects of these medications, percutaneous and surgical ablations in AF patients have evolved as alternative or additional approaches to achieve rhythm-control. Nonetheless, arrhythmia recurrences may also occur after these procedures. Thus, the search for complementary treatment options continues.Ranolazine possesses antiarrhythmic effects in atrial myocytes via blockade of sodium channels. These properties facilitate AF suppression in animal models and human subjects. We report a patient with persistent AF that was refractory to medical management and percutaneous catheter ablation. She has remained in sinus rhythm for at least 18 months after the initiation of ranolazine.

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.